HX-016

N/A

Report date: 2021/12/24 15:25:43

Base Information

Drug NameHX-016

Drug Alias NameHX-016

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody

Mechanisms of ActionAnti-PD-1Vascular endothelial growth factor receptor 2 inhibitors

TargetsProgrammed cell death protein 1Vascular endothelial growth factor receptor 2

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesHanx Biopharmaceutical Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesHanx Biopharmaceutical Co Ltd

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A